The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme

Journal of Neuro-Oncology

Volumn 112, Issue 3, 2013, Pages 393-401

  Aneja, Sanjay ^a   Khullar, Dhruv ^a   Yu, James B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioblastoma multiforme; Health system; Radiation therapy; SEER

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GEOGRAPHIC INFORMATION SYSTEM; GLIOBLASTOMA; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARRIED PERSON; POSTOPERATIVE PERIOD; PRIMARY MEDICAL CARE; REGIONALIZATION; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HEALTHCARE DISPARITIES; HOSPITALS; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RADIOTHERAPY, ADJUVANT; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84885043091     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1068-8     Document Type: Article

References (35)

1. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99(3):467-473. doi: 10.3171/jns.2003.99.3.0467
2. Becker KP, Yu J (2012) Status quo-standard-of-care medical and radiation therapy for glioblastoma. Cancer J 18(1):12-19. doi: 10.1097/PPO. 0b013e318244d7eb
3. Gorey KM (2009) Breast cancer survival in Canada and the USA: meta-analytic evidence of a Canadian advantage in low-income areas. Int J Epidemiol 38(6):1543-1551. doi: 10.1093/ije/dyp193
4. Ricketts TCHG (2007) Mortality and physician supply: does region hold the key to the paradox? Health Serv Res 42(6):2233-2251
5. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K (2011) Physician density and hospitalization for inflammatory bowel disease. Inflamm Bowel Dis 17(2):633-638. doi: 10.1002/ibd.21357
6. Kociol RD, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH, Hernandez AF (2011) Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. Am J Cardiol 108(7):985-991. doi: 10.1016/j.amjcard.2011.05.032
7. Starfield B, Shi L, Grover A, Macinko J (2005) The effects of specialist supply on populations' health: assessing the evidence. Health Aff (Millwood) Suppl Web Exclusives:W5-97-W5-107. doi: 10.1377/hlthaff.w5.97
8. Iglehart JK (2010) Health reform, primary care, and graduate medical education. N Engl J Med 363(6):584-590. doi: 10.1056/NEJMhpr1006115
9. Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts K, Yu JB (2011) Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2011.01.070
10. Aneja S, Aneja S, Bordeaux JS (2012) Association of increased dermatologist density with lower melanoma mortality. Arch Dermatol 148(2):174-178. doi: 10.1001/archdermatol.2011.345
11. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR (2010) Urologist density and county-level urologic cancer mortality. J Clin Oncol 28(15):2499-2504. doi: 10.1200/JCO.2009.26.9597
12. US Department of Health and Human Services HRaSA Area Resource File (ARF): National county-level health resource information database. http://www.arfsys.com. Accessed 18 March 2012
13. Park HS, Gross CP, Makarov DV, Yu JB (2012) Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2011.10.025
14. Koshy MVJ, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107(1):207-212
15. Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26(5B):3773-3779
16. Aghi M BF, Curry WT, Carter BS (2004) Survival after biopsy or resection of supratentorial lobar glioblastoma multiforme: a population-based study, In: Invited talk, congress of neurological surgeons annual meeting
17. Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52(2):161-171
18. Chang SM, Barker FG 2nd (2005) Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer 104(9):1975-1984. doi: 10.1002/cncr.21399
19. Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64(6):628-634. doi: 10.1002/ana.21521
20. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527-1535. doi: 10.1056/NEJMoa065901
21. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649-652
22. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996. doi: 10.1056/NEJMoa043330
23. Sherwood PR, Dahman BA, Donovan HS, Mintz A, Given CW, Bradley CJ (2010) Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol 101(1):67-74. doi: 10.1007/s11060-010-0223-8
24. Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP (2011) Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer 118(17):4228-4234
25. Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117(18):4277-4285. doi: 10.1002/cncr.25969
26. Reyes-Ortiz CAGJ, Zhang DD, Freeman JL (2011) Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging 1:1-11
27. McBride RB, Lebwohl B, Hershman DL, Neugut AI (2010) Impact of socioeconomic status on extent of lymph node dissection for colon cancer. Cancer Epidemiol Biomarkers Prev 19(3):738-745. doi: 10.1158/1055-9965.EPI-09-1086
28. Shishehbor MH, Litaker D, Pothier CE, Lauer MS (2006) Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA 295(7):784-792. doi: 10.1001/jama.295.7.784
29. Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A (2010) Association of socioeconomic position with health behaviors and mortality. JAMA 303(12):1159-1166. doi: 10.1001/jama.2010.297
30. Singal V, Singal AK, Kuo YF (2012) Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol 138(4):715-722. doi: 10.1007/s00432-012-1156-8
31. Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis. Ann Oncol. doi: 10.1093/annonc/mdr578
32. Robbins AS, Siegel RL, Jemal A (2012) Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol 30(4):401-405. doi: 10.1200/JCO.2011.37.5527
33. Terplan MSN, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19-24
34. Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707-715. doi: 10.1016/S1470-2045(12)70164-X
35. Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ (2012) Underascertainment of radiotherapy receipt in surveillance, Epidemiology, and End Results registry data. Cancer 118(2):333-341. doi: 10.1002/cncr.26295